Insider transactions

EDGAR

BNB STANDARD CORPORATION

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-19.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–11 of 11

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-21 Filed 2026-10-22Rosenfeld Margaret Natalie Officer: Chief Strategy Legal Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (363,636)
Acquired (A)363,636——363,636Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
  • F2 The restricted stock units were granted under the BNB Standard Corporation 2026 Inducement Plan as a material inducement to employment of the reporting person, in accordance with Nasdaq Listing Rule 5635(c)(4). Twenty-five percent of the units (90,909) vest on July 27, 2027, and the remainder vest in twelve substantially equal quarterly installments through July 27, 2030, subject to the continued service of the reporting person through each vesting date.
Open filing 0001482541-26-000062 Read from the filing’s XML Dispute this row
2026-09-17 Filed 2026-10-07YZILabs Management Ltd. 10% ownerZhao Changpeng 10% owner
X

Exercise of in-the-money or at-the-money derivative security

Common Stock, par value $0.00001 per share
Acquired (A)2,180,631——4,331,112Direct (D) No
F1, F2, F3
  • F1 The exercise price is $0.00001 per share.
  • F2 This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company (YZi Labs) and Changpeng Zhao (Mr. Zhao), a citizen of the United Arab Emirates (collectively, the Reporting Persons). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • F3 Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.
Open filing 0000921895-26-002756 Read from the filing’s XML Dispute this row
2026-09-17 Filed 2026-10-07YZILabs Management Ltd. 10% ownerZhao Changpeng 10% owner
X

Exercise of in-the-money or at-the-money derivative security

Common Stock, par value $0.00001 per share
Acquired (A)5,418,633——9,749,745Direct (D) No
F1, F2, F3
  • F1 The exercise price is $0.00001 per share.
  • F2 This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company (YZi Labs) and Changpeng Zhao (Mr. Zhao), a citizen of the United Arab Emirates (collectively, the Reporting Persons). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • F3 Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.
Open filing 0000921895-26-002756 Read from the filing’s XML Dispute this row
2026-09-17 Filed 2026-10-07YZILabs Management Ltd. 10% ownerZhao Changpeng 10% owner
X

Exercise of in-the-money or at-the-money derivative security

Derivative security: Strategic Advisor Warrants — underlying Common Stock, $0.00001 per share (2,180,631)
Disposed (D)2,180,631——1,383,728Direct (D) No
F1, F4, F5, F2, F3
  • F1 The exercise price is $0.00001 per share.
  • F4 The Strategic Advisor Warrants are immediately exercisable at an exercise price equal to $0.00001 per share and may be exercised at any point on or prior to 5:00 p.m. on August 5, 2030, subject to the SAW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Strategic Advisor Warrants, the holder may increase or decrease the SAW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 9.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Strategic Advisor Warrants is 9.99% of the Issuer's then outstanding shares of Common Stock (the SAW Beneficial Ownership Limitation). On September 17, YZi Labs exercised 2,180,631 Strategic Advisor Warrants, representing 2,180,631 shares of Common Stock, at an exercise price of $0.00001 per share.
  • F5 Each of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants either provide, or the holder has elected, that the holder shall not have the right to exercise any portion of any such warrants to the extent that after giving effect to such issuance after exercise, such holder and certain of its affiliates would be deemed to beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than a certain percentage of the Issuer's then outstanding shares of common stock (the Beneficial Ownership Limitations), as adjusted pursuant to the terms of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants. On September 17, 2026, the Issuer agreed to waive the required 61 days' notice period to the Issuer with respect to an increase in the Beneficial Ownership Limitations under the terms of each of the Pre-Funded Warrants and the Strategic Advisor Warrants held by YZi Labs.
  • F2 This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company (YZi Labs) and Changpeng Zhao (Mr. Zhao), a citizen of the United Arab Emirates (collectively, the Reporting Persons). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • F3 Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.
Open filing 0000921895-26-002756 Read from the filing’s XML Dispute this row
2026-09-17 Filed 2026-10-07YZILabs Management Ltd. 10% ownerZhao Changpeng 10% owner
X

Exercise of in-the-money or at-the-money derivative security

Derivative security: Pre-Funded Warrants — underlying Common Stock, $0.00001 per share (5,418,633)
Disposed (D)5,418,633——2,331,877Direct (D) No
F1, F6, F5, F2, F3
  • F1 The exercise price is $0.00001 per share.
  • F6 The Pre-Funded Warrants are immediately exercisable at an initial exercise price equal to $0.00001 per share and may be exercised at any time until the Pre-Funded Warrants are exercised in full, subject to the PFW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Pre-Funded Warrants, the holder may increase or decrease the PFW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 19.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Pre-Funded Warrants is 19.99% of the Issuer's then outstanding shares of Common Stock (the PFW Beneficial Ownership Limitation). On September 17, 2026, YZi Labs exercised 5,418,633 Pre-Funded Warrants, representing 5,418,633 shares of Common Stock, at an exercise price of $0.00001 per share.
  • F5 Each of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants either provide, or the holder has elected, that the holder shall not have the right to exercise any portion of any such warrants to the extent that after giving effect to such issuance after exercise, such holder and certain of its affiliates would be deemed to beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than a certain percentage of the Issuer's then outstanding shares of common stock (the Beneficial Ownership Limitations), as adjusted pursuant to the terms of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants. On September 17, 2026, the Issuer agreed to waive the required 61 days' notice period to the Issuer with respect to an increase in the Beneficial Ownership Limitations under the terms of each of the Pre-Funded Warrants and the Strategic Advisor Warrants held by YZi Labs.
  • F2 This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company (YZi Labs) and Changpeng Zhao (Mr. Zhao), a citizen of the United Arab Emirates (collectively, the Reporting Persons). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • F3 Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.
Open filing 0000921895-26-002756 Read from the filing’s XML Dispute this row
2026-09-17 Filed 2026-09-21YZILabs Management Ltd. 10% owner
X

Exercise of in-the-money or at-the-money derivative security

Common Stock, par value $0.00001 per share
Acquired (A)2,180,631——4,331,112Direct (D) No
F1, F2, F3
  • F1 The exercise price is $0.00001 per share.
  • F2 This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company (YZi Labs) and Changpeng Zhao (Mr. Zhao), a citizen of the United Arab Emirates (collectively, the Reporting Persons). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • F3 Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.
Open filing 0000921895-26-002600 Read from the filing’s XML Dispute this row
2026-09-17 Filed 2026-09-21YZILabs Management Ltd. 10% owner
X

Exercise of in-the-money or at-the-money derivative security

Common Stock, par value $0.00001 per share
Acquired (A)5,418,633——9,749,745Direct (D) No
F1, F2, F3
  • F1 The exercise price is $0.00001 per share.
  • F2 This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company (YZi Labs) and Changpeng Zhao (Mr. Zhao), a citizen of the United Arab Emirates (collectively, the Reporting Persons). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • F3 Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.
Open filing 0000921895-26-002600 Read from the filing’s XML Dispute this row
2026-09-17 Filed 2026-09-21YZILabs Management Ltd. 10% owner
X

Exercise of in-the-money or at-the-money derivative security

Derivative security: Strategic Advisor Warrants — underlying Common Stock, $0.00001 per share (2,180,631)
Disposed (D)2,180,631——1,383,728Direct (D) No
F1, F4, F5, F2, F3
  • F1 The exercise price is $0.00001 per share.
  • F4 The Strategic Advisor Warrants are immediately exercisable at an exercise price equal to $0.00001 per share and may be exercised at any point on or prior to 5:00 p.m. on August 5, 2030, subject to the SAW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Strategic Advisor Warrants, the holder may increase or decrease the SAW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 9.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Strategic Advisor Warrants is 9.99% of the Issuer's then outstanding shares of Common Stock (the SAW Beneficial Ownership Limitation). On September 17, YZi Labs exercised 2,180,631 Strategic Advisor Warrants, representing 2,180,631 shares of Common Stock, at an exercise price of $0.00001 per share.
  • F5 Each of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants either provide, or the holder has elected, that the holder shall not have the right to exercise any portion of any such warrants to the extent that after giving effect to such issuance after exercise, such holder and certain of its affiliates would be deemed to beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than a certain percentage of the Issuer's then outstanding shares of common stock (the Beneficial Ownership Limitations), as adjusted pursuant to the terms of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants. On September 17, 2026, the Issuer agreed to waive the required 61 days' notice period to the Issuer with respect to an increase in the Beneficial Ownership Limitations under the terms of each of the Pre-Funded Warrants and the Strategic Advisor Warrants held by YZi Labs.
  • F2 This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company (YZi Labs) and Changpeng Zhao (Mr. Zhao), a citizen of the United Arab Emirates (collectively, the Reporting Persons). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • F3 Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.
Open filing 0000921895-26-002600 Read from the filing’s XML Dispute this row
2026-09-17 Filed 2026-09-21YZILabs Management Ltd. 10% owner
X

Exercise of in-the-money or at-the-money derivative security

Derivative security: Pre-Funded Warrants — underlying Common Stock, $0.00001 per share (5,418,633)
Disposed (D)5,418,633——2,331,877Direct (D) No
F1, F6, F5, F2, F3
  • F1 The exercise price is $0.00001 per share.
  • F6 The Pre-Funded Warrants are immediately exercisable at an initial exercise price equal to $0.00001 per share and may be exercised at any time until the Pre-Funded Warrants are exercised in full, subject to the PFW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Pre-Funded Warrants, the holder may increase or decrease the PFW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 19.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Pre-Funded Warrants is 19.99% of the Issuer's then outstanding shares of Common Stock (the PFW Beneficial Ownership Limitation). On September 17, 2026, YZi Labs exercised 5,418,633 Pre-Funded Warrants, representing 5,418,633 shares of Common Stock, at an exercise price of $0.00001 per share.
  • F5 Each of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants either provide, or the holder has elected, that the holder shall not have the right to exercise any portion of any such warrants to the extent that after giving effect to such issuance after exercise, such holder and certain of its affiliates would be deemed to beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than a certain percentage of the Issuer's then outstanding shares of common stock (the Beneficial Ownership Limitations), as adjusted pursuant to the terms of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants. On September 17, 2026, the Issuer agreed to waive the required 61 days' notice period to the Issuer with respect to an increase in the Beneficial Ownership Limitations under the terms of each of the Pre-Funded Warrants and the Strategic Advisor Warrants held by YZi Labs.
  • F2 This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company (YZi Labs) and Changpeng Zhao (Mr. Zhao), a citizen of the United Arab Emirates (collectively, the Reporting Persons). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • F3 Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.
Open filing 0000921895-26-002600 Read from the filing’s XML Dispute this row
2026-04-06 Filed 2026-04-09Miller William B Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (363,636)
Acquired (A)363,6360—363,636Direct (D) No
F1, F2
  • F1 RSUs convert into common stock on a one-for-one basis.
  • F2 25% of the RSUs (90,909 shares) vest on April 6, 2027, with the remaining RSUs vesting in equal quarterly installments thereafter through April 6, 2030, subject to the Participant's continued service with the Company through each applicable vesting date. The RSUs were granted pursuant to the CEA Industries Inc. 2026 Inducement Plan.
Open filing 0001493152-26-015912 Read from the filing’s XML Dispute this row
2025-12-03 Filed 2026-03-02Thomas Hans Director
J

Other acquisition or disposition (describe transaction)

Derivative security: Warrants to purchase Common Stock — underlying Common Stock (250,000) — exercise price 10.23
Disposed (D)250,0000—390,099Indirect (I) By 10X Capital Partners LLCNo
F3, F4
  • F3 Reflects the effective assignment of such warrants to a third-party.
  • F4 Reporting Person is the manager of 10X Capital Partners LLC and may be deemed to have beneficial ownership of the securities held by 10X Capital Partners LLC. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Open filing 0001493152-26-008601 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-18. Prior quarter ending 2026-06-30: 9,170 filings read.

Showing 1–50 of 64

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
VANGUARD CAPITAL MANAGEMENT LLC 1,810,279 SH10,662,543 dollarsLower by 89,404 Prior quarter: 1,899,683Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
Saba Capital Management, L.P. 988,726 SH4,691,713 dollarsLower by 434,914 Prior quarter: 1,423,640Open filing 0001062993-26-006091 Filed 2026-11-16 Dispute this row
MMCAP International Inc. SPC 742,575 SH18,964 dollarsUnchanged Prior quarter: 742,575Open filing 0000912282-26-001452 Filed 2026-11-12 Dispute this row
Arrington Capital Management, LLC 736,090 SH1,778,142 dollarsLower by 30,000 Prior quarter: 766,090Open filing 0002087115-26-000004 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager733,851 SH4,322,382 dollarsLower by 48,100 Prior quarter: 781,951Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
UBS Group AG Partly reported under another manager608,709 SH3,470,447 dollarsHigher by 199,988 Prior quarter: 408,721Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Empery Asset Management, LP 500,000 SH10,760 dollarsUnchanged Prior quarter: 500,000Open filing 0000919574-26-008014 Filed 2026-11-16 Dispute this row
FRANKLIN TEMPLETON INC Partly reported under another manager495,049 SH74,768 dollarsNot in the prior quarter’s filings read Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager420,299 SH2,477,282 dollarsLower by 56,547 Prior quarter: 476,846Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
BTG Pactual Asset Management US LLC 396,040 SH0 dollarsUnchanged Prior quarter: 396,040Open filing 0001569579-26-000005 Filed 2026-11-16 Dispute this row
JANE STREET GROUP, LLC Partly reported under another manager316,170 SH725,606 dollarsHigher by 50,224 Prior quarter: 265,946Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
MILLENNIUM MANAGEMENT LLC 266,972 SH1,572,465 dollarsLower by 29,605 Prior quarter: 296,577Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
Brevan Howard Capital Management LP Partly reported under another manager257,418 SH1,516,192 dollarsLower by 1,261,800 Prior quarter: 1,519,218Open filing 0000905148-26-004906 Filed 2026-11-16 Dispute this row
Clear Street Group Inc. 251,625 SH8,191 dollarsHigher by 399 Prior quarter: 251,226Open filing 0001881567-26-000006 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 224,698 SH1,323,471 dollarsLower by 34,931 Prior quarter: 259,629Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Harraden Circle Investments, LLC 200,000 SH3,260 dollarsUnchanged Prior quarter: 200,000Open filing 0001910592-26-000011 Filed 2026-11-16 Dispute this row
Feynman Point Asset Management LLC 198,020 SH29,703 dollarsUnchanged Prior quarter: 198,020Open filing 0001420506-26-002900 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager179,561 SH1,057,614 dollarsLower by 14,800 Prior quarter: 194,361Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
HGC Investment Management Inc. 123,763 SH18,564 dollarsNot in the prior quarter’s filings read Open filing 0001711200-26-000004 Filed 2026-11-16 Dispute this row
JANE STREET GROUP, LLC Option: Call Partly reported under another manager116,900 SH688,541 dollarsNot in the prior quarter’s filings read Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager107,657 SH407,835 dollarsHigher by 16,563 Prior quarter: 91,094Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
CITADEL ADVISORS LLC Option: Put Partly reported under another manager90,400 SH532,456 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager82,828 SH487,857 dollarsLower by 12,150 Prior quarter: 94,978Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
SIMPLEX TRADING, LLC Option: Put 76,600 SH451,174 dollarsHigher by 76,100 Prior quarter: 500Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
GROUP ONE TRADING LLC Option: Put 59,400 SH349,866 dollarsNot in the prior quarter’s filings read Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row
One68 Global Capital, LLC 56,400 SH846 dollarsNot in the prior quarter’s filings read Open filing 0001755535-26-000015 Filed 2026-11-13 Dispute this row
MORGAN STANLEY Partly reported under another manager56,207 SH331,060 dollarsHigher by 4,317 Prior quarter: 51,890Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Balyasny Asset Management L.P. 53,443 SH314,779 dollarsNot in the prior quarter’s filings read Open filing 0001193125-26-463223 Filed 2026-11-16 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager47,330 SH190,179 dollarsLower by 17,410 Prior quarter: 64,740Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
WOLVERINE ASSET MANAGEMENT LLC Partly reported under another manager46,718 SH7,621 dollarsHigher by 1,200 Prior quarter: 45,518Open filing 0001279891-26-000016 Filed 2026-11-02 Dispute this row
JANE STREET GROUP, LLC Option: Put Partly reported under another manager42,200 SH248,558 dollarsNot in the prior quarter’s filings read Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
IMC-Chicago, LLC Option: Call 40,100 SH236,189 dollarsNot in the prior quarter’s filings read Open filing 0001452861-26-000007 Filed 2026-11-05 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 40,000 SH235,600 dollarsNot in the prior quarter’s filings read Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
CITADEL ADVISORS LLC Option: Call Partly reported under another manager38,200 SH224,998 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
Jump Financial, LLC Partly reported under another manager35,991 SH211,987 dollarsNot in the prior quarter’s filings read Open filing 0000905148-26-004786 Filed 2026-11-13 Dispute this row
Virtu Financial LLC Partly reported under another manager27,526 SH97 dollarsLower by 441 Prior quarter: 27,967Open filing 0001533964-26-000015 Filed 2026-11-17 Dispute this row
SIMPLEX TRADING, LLC 26,443 SH155,749 dollarsHigher by 20,045 Prior quarter: 6,398Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
BARCLAYS PLC Partly reported under another manager25,318 SH149,124 dollarsNot in the prior quarter’s filings read Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager25,100 SH147,839 dollarsNot in the prior quarter’s filings read Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
Step Capital Management Pte. Ltd. Partly reported under another manager25,000 SH147,250 dollarsUnchanged Prior quarter: 25,000Open filing 0002091341-26-000005 Filed 2026-11-13 Dispute this row
Well Done, LLC 20,000 SH204 dollarsUnchanged Prior quarter: 20,000Open filing 0001951757-26-001714 Filed 2026-10-20 Dispute this row
Modera Wealth Management, LLC 20,000 SH0 dollarsUnchanged Prior quarter: 20,000Open filing 0001398344-26-018981 Filed 2026-10-28 Dispute this row
IMC-Chicago, LLC Option: Put 19,400 SH114,266 dollarsNot in the prior quarter’s filings read Open filing 0001452861-26-000007 Filed 2026-11-05 Dispute this row
Warberg Asset Management LLC 17,500 SH285 dollarsLower by 17,500 Prior quarter: 35,000Open filing 0001597506-26-000004 Filed 2026-11-02 Dispute this row
GROUP ONE TRADING LLC Option: Call 16,100 SH94,829 dollarsNot in the prior quarter’s filings read Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row
PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager15,900 SH94 dollarsUnchanged Prior quarter: 15,900Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager14,628 SH86,159 dollarsHigher by 10,328 Prior quarter: 4,300Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
Aster Capital Management (DIFC) Ltd Partly reported under another manager14,334 SH84,427 dollarsNot in the prior quarter’s filings read Open filing 0002040915-26-000006 Filed 2026-11-12 Dispute this row
CITIZENS FINANCIAL GROUP INC/RI Partly reported under another manager14,144 SH83,308 dollarsUnchanged Prior quarter: 14,144Open filing 0000759944-26-000210 Filed 2026-10-23 Dispute this row
Engineers Gate Manager LP 11,973 SH70,521 dollarsNot in the prior quarter’s filings read Open filing 0001620220-26-000010 Filed 2026-11-16 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • MARSHALL WACE, LLP 69,981 SH
  • nVerses Capital, LLC 20,833 SH
  • Weiss Asset Management LP 14,634 SH
  • Shay Capital LLC 12,126 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Vanguard Capital Management Common Stock4.962,046,01009/30/2026 Filed 2026-10-30SCHEDULE 13G/AAmendment 1Open filing 0002100119-26-001573 Dispute this row
YZILabs Management Ltd. Common Stock, par value $0.00001 per share19.999,749,745.0009/17/2026 Filed 2026-09-21SCHEDULE 13D/AAmendment 5Open filing 0000921895-26-002598 Dispute this row
Changpeng Zhao Common Stock, par value $0.00001 per share19.999,749,745.0009/17/2026 Filed 2026-09-21SCHEDULE 13D/AAmendment 5Open filing 0000921895-26-002598 Dispute this row
YZILabs Management Ltd. Common Stock, par value $0.00001 per share5.072,150,481.0006/23/2026 Filed 2026-06-24SCHEDULE 13D/AAmendment 4Open filing 0000921895-26-001667 Dispute this row
Changpeng Zhao Common Stock, par value $0.00001 per share5.072,150,481.0006/23/2026 Filed 2026-06-24SCHEDULE 13D/AAmendment 4Open filing 0000921895-26-001667 Dispute this row
Baucus Sieben Max Common Stock, par value $0.00001 per share00.0006/23/2026 Filed 2026-06-24SCHEDULE 13D/AAmendment 4Open filing 0000921895-26-001667 Dispute this row
Chapman James David Common Stock, par value $0.00001 per share00.0006/23/2026 Filed 2026-06-24SCHEDULE 13D/AAmendment 4Open filing 0000921895-26-001667 Dispute this row
Guillen Goody Teresa Marie Common Stock, par value $0.00001 per share00.0006/23/2026 Filed 2026-06-24SCHEDULE 13D/AAmendment 4Open filing 0000921895-26-001667 Dispute this row
He Jiajin Common Stock, par value $0.00001 per share4.952,099,644.0006/23/2026 Filed 2026-06-24SCHEDULE 13D/AAmendment 4Open filing 0000921895-26-001667 Dispute this row
Odagiu Alex Common Stock, par value $0.00001 per share0.014,918.0006/23/2026 Filed 2026-06-24SCHEDULE 13D/AAmendment 4Open filing 0000921895-26-001667 Dispute this row
Roszak Matthew Common Stock, par value $0.00001 per share00.0006/23/2026 Filed 2026-06-24SCHEDULE 13D/AAmendment 4Open filing 0000921895-26-001667 Dispute this row
Zhang Ling Common Stock, par value $0.00001 per share00.0006/23/2026 Filed 2026-06-24SCHEDULE 13D/AAmendment 4Open filing 0000921895-26-001667 Dispute this row
Vanguard Capital Management Common Stock5.072,176,59503/31/2026 Filed 2026-04-29SCHEDULE 13GOpen filing 0002100119-26-000299 Dispute this row
YZILabs Management Ltd. Common Stock, par value $0.00001 per share4.92,150,481.0003/13/2026 Filed 2026-03-16SCHEDULE 13D/AAmendment 3Open filing 0001193805-26-000268 Dispute this row
Changpeng Zhao Common Stock, par value $0.00001 per share4.92,150,481.0003/13/2026 Filed 2026-03-16SCHEDULE 13D/AAmendment 3Open filing 0001193805-26-000268 Dispute this row
Baucus Max Common Stock, par value $0.00001 per share0.00.0003/13/2026 Filed 2026-03-16SCHEDULE 13D/AAmendment 3Open filing 0001193805-26-000268 Dispute this row
Chapman James David Common Stock, par value $0.00001 per share0.00.0003/13/2026 Filed 2026-03-16SCHEDULE 13D/AAmendment 3Open filing 0001193805-26-000268 Dispute this row
Guill?n Goody Teresa Marie Common Stock, par value $0.00001 per share0.00.0003/13/2026 Filed 2026-03-16SCHEDULE 13D/AAmendment 3Open filing 0001193805-26-000268 Dispute this row
He Jiajin Common Stock, par value $0.00001 per share4.62,099,644.0003/13/2026 Filed 2026-03-16SCHEDULE 13D/AAmendment 3Open filing 0001193805-26-000268 Dispute this row
Odagiu Alex Common Stock, par value $0.00001 per share0.04,918.0003/13/2026 Filed 2026-03-16SCHEDULE 13D/AAmendment 3Open filing 0001193805-26-000268 Dispute this row
Roszak Matthew Common Stock, par value $0.00001 per share0.00.0003/13/2026 Filed 2026-03-16SCHEDULE 13D/AAmendment 3Open filing 0001193805-26-000268 Dispute this row
Zhang Ling Common Stock, par value $0.00001 per share0.00.0003/13/2026 Filed 2026-03-16SCHEDULE 13D/AAmendment 3Open filing 0001193805-26-000268 Dispute this row
YZILabs Management Ltd. Common Stock, par value $0.00001 per share4.92,150,481.0012/29/2025 Filed 2025-12-31SCHEDULE 13D/AAmendment 2Open filing 0001193805-25-001807 Dispute this row
Changpeng Zhao Common Stock, par value $0.00001 per share4.92,150,481.0012/29/2025 Filed 2025-12-31SCHEDULE 13D/AAmendment 2Open filing 0001193805-25-001807 Dispute this row
Baucus Sieben Max Common Stock, par value $0.00001 per share00.0012/29/2025 Filed 2025-12-31SCHEDULE 13D/AAmendment 2Open filing 0001193805-25-001807 Dispute this row
Chapman James David Common Stock, par value $0.00001 per share00.0012/29/2025 Filed 2025-12-31SCHEDULE 13D/AAmendment 2Open filing 0001193805-25-001807 Dispute this row
Guillen Goody Teresa Marie Common Stock, par value $0.00001 per share00.0012/29/2025 Filed 2025-12-31SCHEDULE 13D/AAmendment 2Open filing 0001193805-25-001807 Dispute this row
He Jiajin Common Stock, par value $0.00001 per share4.62,099,644.0012/29/2025 Filed 2025-12-31SCHEDULE 13D/AAmendment 2Open filing 0001193805-25-001807 Dispute this row
Odagiu Alex Common Stock, par value $0.00001 per share0.014,918.0012/29/2025 Filed 2025-12-31SCHEDULE 13D/AAmendment 2Open filing 0001193805-25-001807 Dispute this row
Roszak Matthew Common Stock, par value $0.00001 per share00.0012/29/2025 Filed 2025-12-31SCHEDULE 13D/AAmendment 2Open filing 0001193805-25-001807 Dispute this row
Zhang Ling Common Stock, par value $0.00001 per share00.0012/29/2025 Filed 2025-12-31SCHEDULE 13D/AAmendment 2Open filing 0001193805-25-001807 Dispute this row
YZILabs Management Ltd. Common Stock, par value $0.00001 per share4.92,150,481.0012/19/2025 Filed 2025-12-23SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-003388 Dispute this row
Changpeng Zhao Common Stock, par value $0.00001 per share4.92,150,481.0012/19/2025 Filed 2025-12-23SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-003388 Dispute this row
Baucus Sieben Max Common Stock, par value $0.00001 per share00.0012/19/2025 Filed 2025-12-23SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-003388 Dispute this row
Chapman James David Common Stock, par value $0.00001 per share00.0012/19/2025 Filed 2025-12-23SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-003388 Dispute this row
Guillen Goody Teresa Marie Common Stock, par value $0.00001 per share00.0012/19/2025 Filed 2025-12-23SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-003388 Dispute this row
He Jiajin Common Stock, par value $0.00001 per share4.62,099,644.0012/19/2025 Filed 2025-12-23SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-003388 Dispute this row
Odagiu Alex Common Stock, par value $0.00001 per share0.014,918.0012/19/2025 Filed 2025-12-23SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-003388 Dispute this row
Roszak Matthew Common Stock, par value $0.00001 per share00.0012/19/2025 Filed 2025-12-23SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-003388 Dispute this row
Zhang Ling Common Stock, par value $0.00001 per share00.0012/19/2025 Filed 2025-12-23SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-003388 Dispute this row
YZILabs Management Ltd. Common Stock, par value $0.00001 per share5.02,150,481.0011/19/2025 Filed 2025-11-26SCHEDULE 13DOpen filing 0000921895-25-003215 Dispute this row
Changpeng Zhao Common Stock, par value $0.00001 per share5.02,150,481.0011/19/2025 Filed 2025-11-26SCHEDULE 13DOpen filing 0000921895-25-003215 Dispute this row
Alta Partners LLC Common Stock0.138,180.0009/30/2025 Filed 2025-10-10SCHEDULE 13G/AAmendment 1Open filing 0001896206-25-000006 Dispute this row
Alta Partners LLC Common Stock6.457,330.0007/28/2025 Filed 2025-07-31SCHEDULE 13GOpen filing 0001094891-25-000016 Dispute this row
111 Equity Group LLC Common Stock0.00.0007/28/2025 Filed 2025-07-30SCHEDULE 13D/AAmendment 2Open filing 0001104659-25-072078 Dispute this row
Rochel M. Kassirer Common Stock0.00.0007/28/2025 Filed 2025-07-30SCHEDULE 13D/AAmendment 2Open filing 0001104659-25-072078 Dispute this row
Chaim Herzog Common Stock0.00.0007/28/2025 Filed 2025-07-30SCHEDULE 13D/AAmendment 2Open filing 0001104659-25-072078 Dispute this row
Lance Brock Finlinson Common Stock00.0007/28/2025 Filed 2025-07-30SCHEDULE 13D/AAmendment 1Open filing 0001641172-25-021534 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,540,664 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020166,957
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,403

Filings made before the SEC required XML are listed, not extracted.

Back to BNB STANDARD CORPORATION